Peer review reports
From: Antitumor effects of erlotinib in combination with berberine in A431 cells
Original Submission | ||
---|---|---|
17 May 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
2 Aug 2022 | Reviewed | Reviewer Report |
8 Jan 2023 | Reviewed | Reviewer Report - Johanna Varghese |
23 Jan 2023 | Author responded | Author comments - Yanping Huang |
Resubmission - Version 3 | ||
23 Jan 2023 | Submitted | Manuscript version 3 |
24 Jan 2023 | Author responded | Author comments - Yanping Huang |
Resubmission - Version 4 | ||
24 Jan 2023 | Submitted | Manuscript version 4 |
10 Feb 2023 | Reviewed | Reviewer Report - Johanna Varghese |
1 Mar 2023 | Author responded | Author comments - Yanping Huang |
Resubmission - Version 5 | ||
1 Mar 2023 | Submitted | Manuscript version 5 |
1 Mar 2023 | Author responded | Author comments - Yanping Huang |
Resubmission - Version 6 | ||
1 Mar 2023 | Submitted | Manuscript version 6 |
Publishing | ||
7 Mar 2023 | Editorially accepted | |
11 May 2023 | Article published | 10.1186/s40360-023-00661-2 |